Noom competitor OurPath rebrands as Second Nature, raises $10M Series A
Back in 2018, OurPath emerged as a startup in the U.K. tackling the problem of...
Xilis believes cultivating micro-tumors may hold the key to more effective cancer treatments
Despite near-miraculous advances in the treatment of cancer in the U.S. and...
Ginkgo Bioworks’ dev shop for genetic programming is now worth $4 billion
Ginkgo Bioworks is now worth $4 billion after a $290 million capital infusion...